Rejoinder

Affiliations

¹ 1 The Department of Bioethics, National Institutes of Health, Bethesda, Maryland and Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, Michigan, USA.
² 2 Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ 3 University of Sheffield, Sheffield, UK.

Free article

Comment

Scott Yh Kim et al. Clin Trials. 2018 Feb.

Free article

. 2018 Feb;15(1):27-28.

doi: 10.1177/1740774517746629.

¹ 1 The Department of Bioethics, National Institutes of Health, Bethesda, Maryland and Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, Michigan, USA.
² 2 Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ 3 University of Sheffield, Sheffield, UK.

No abstract available

Comment on

Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
Kim SY, Flory J, Relton C. Kim SY, et al. Clin Trials. 2018 Feb;15(1):9-16. doi: 10.1177/1740774517746620. Epub 2017 Dec 11. Clin Trials. 2018. PMID: 29224380 Free PMC article.
Innovative approaches to informed consent for randomized clinical trials: Identifying the ethical challenges.
Wendler D. Wendler D. Clin Trials. 2018 Feb;15(1):17-20. doi: 10.1177/1740774517746621. Epub 2017 Dec 17. Clin Trials. 2018. PMID: 29250988 Free PMC article. No abstract available.
TwiC or treat? Are trials within cohorts ethically defensible?
Weijer C, Goldstein CE, Taljaard M. Weijer C, et al. Clin Trials. 2018 Feb;15(1):21-24. doi: 10.1177/1740774517746622. Epub 2017 Dec 17. Clin Trials. 2018. PMID: 29250989 Free PMC article. No abstract available.